63 related articles for article (PubMed ID: 10805404)
1. Long-term administration of D-NAME induces hemodynamic and structural changes in the cardiovascular system.
Babál P; Pechánová O; Bernátová I
Physiol Res; 2000; 49(1):47-54. PubMed ID: 10805404
[TBL] [Abstract][Full Text] [Related]
2. Structural alterations in the heart after long-term L-NAME and D-NAME treatment.
Pechánová O; Bernátová I; Babál P
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():6-9. PubMed ID: 10707823
[TBL] [Abstract][Full Text] [Related]
3. Chronic low-dose L-NAME treatment increases nitric oxide production and vasorelaxation in normotensive rats.
Bernátová I; Kopincová J; Púzserová A; Janega P; Babál P
Physiol Res; 2007; 56 Suppl 2():S17-S24. PubMed ID: 17824811
[TBL] [Abstract][Full Text] [Related]
4. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
Sanada S; Node K; Minamino T; Takashima S; Ogai A; Asanuma H; Ogita H; Liao Y; Asakura M; Kim J; Hori M; Kitakaze M
Hypertension; 2003 Apr; 41(4):963-7. PubMed ID: 12629037
[TBL] [Abstract][Full Text] [Related]
5. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
Bernátová I; Pechánová O; Simko F
Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
[TBL] [Abstract][Full Text] [Related]
6. Effect of captopril on cyclic nucleotide concentrations during long-term NO synthase inhibition.
Pechánová O; Bernátová I
Physiol Res; 2000; 49(1):55-63. PubMed ID: 10805405
[TBL] [Abstract][Full Text] [Related]
7. Pentaerythrityl tetranitrate attenuates structural changes in conduit arteries evoked by long-term NO-synthase inhibition.
Kristek F
Br J Pharmacol; 2000 May; 130(2):450-6. PubMed ID: 10807685
[TBL] [Abstract][Full Text] [Related]
8. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.
Martin PY; Ohara M; Gines P; Xu DL; St John J; Niederberger M; Schrier RW
J Clin Invest; 1998 Jan; 101(1):235-42. PubMed ID: 9421486
[TBL] [Abstract][Full Text] [Related]
10. L-NAME-induced protein remodeling and fibrosis in the rat heart.
Pechánová O; Bernátová I; Pelouch V; Babál P
Physiol Res; 1999; 48(5):353-62. PubMed ID: 10625224
[TBL] [Abstract][Full Text] [Related]
11. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat.
Ye VZ; Hodge G; Yong JL; Duggan KA
Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372
[TBL] [Abstract][Full Text] [Related]
12. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
Takeuchi K; Takehara K; Kato S
J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
[TBL] [Abstract][Full Text] [Related]
13. Hypertensive response to chronic NG-nitro-L-arginine methyl ester (L-NAME) treatment is similar in immature and adult Wistar rats.
Zicha J; Pechánová O; Dobesová Z; Kunes J
Clin Sci (Lond); 2003 Oct; 105(4):483-9. PubMed ID: 12816535
[TBL] [Abstract][Full Text] [Related]
14. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular system of offsprings of hypertensive rats with defective nitric oxide production.
Gerová M; Bernátová I; Török J; Juráni M
Physiol Res; 2002; 51(5):465-74. PubMed ID: 12470199
[TBL] [Abstract][Full Text] [Related]
16. Effects of aminoguanidine and N(omega)-nitro-L-arginine methyl ester on vascular hyporeactivity induced by endotoxaemia.
Ismailoglu UB; Pekiner C; Yorganci K; Sahin-Erdemli I
Eur J Surg; 2001 Nov; 167(11):803-9. PubMed ID: 11848232
[TBL] [Abstract][Full Text] [Related]
17. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
Sacco G; Evangelista S; Criscuoli M; Goso C; Bigioni M; Binaschi M; Manzini S; Maggi CA
Eur J Pharmacol; 2005 Mar; 511(2-3):167-74. PubMed ID: 15792785
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of pulse wave velocity precedes vascular structural changes of the aorta in rats treated with N(omega)-nitro-L-arginine methyl ester.
Kameyama H; Takeda K; Kusaba T; Narumiya H; Tanda S; Kuwahara N; Yamada K; Tamagaki K; Okigaki M; Hatta T; Sasaki S
Hypertens Res; 2005 May; 28(5):439-45. PubMed ID: 16156508
[TBL] [Abstract][Full Text] [Related]
19. [Beneficial effects of exogenous NO donors on morphologic changes induced by long-term administration of NO synthase blockers].
Kristek F; Varga I
Bratisl Lek Listy; 2001; 102(4):200-8. PubMed ID: 11723679
[TBL] [Abstract][Full Text] [Related]
20. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
